当前位置：
X-MOL 学术
›
Catheter. Cardiovasc. Interv.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry
Catheterization & Cardiovascular Interventions ( IF 2.3 ) Pub Date : 2021-09-17 , DOI: 10.1002/ccd.29941 Guilherme F. Attizzani 1 , Luis Augusto P. Dallan 1 , John K. Forrest 2 , Michael J. Reardon 3 , Wilson Y. Szeto 4 , Fang Liu 5 , Marc Pelletier 1
Catheterization & Cardiovascular Interventions ( IF 2.3 ) Pub Date : 2021-09-17 , DOI: 10.1002/ccd.29941 Guilherme F. Attizzani 1 , Luis Augusto P. Dallan 1 , John K. Forrest 2 , Michael J. Reardon 3 , Wilson Y. Szeto 4 , Fang Liu 5 , Marc Pelletier 1
Affiliation
To assess the safety profile of redo-TAVR procedures from patients in the transcatheter valve therapy (TVT) Registry.
中文翻译：
使用超环状、自膨胀 Evolut 平台重做经导管主动脉瓣置换术：来自经导管瓣膜治疗登记处的见解
评估经导管瓣膜治疗 (TVT) 登记中患者重做 TAVR 程序的安全性。
更新日期：2021-09-17
中文翻译：
使用超环状、自膨胀 Evolut 平台重做经导管主动脉瓣置换术：来自经导管瓣膜治疗登记处的见解
评估经导管瓣膜治疗 (TVT) 登记中患者重做 TAVR 程序的安全性。
京公网安备 11010802027423号